DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-92,620

NOVARTIS PHARMACEUTICALS CORPORATION
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH (NIBR) GROUP
EARLY BIOANALYTICS & TECHNOLOGY (EBT) DEPARTMENT
INCLUDING ON-SITE LEASED WORKERS FROM INVENTIV, WUXI APPTEC,
WUXI APPTEC XENOBIOTIC LABORATORIES, COVANCE US, COVANCE UK,
CHARLES RIVER CANADA, VEEDA CLINICAL RESEARCH PVT. LTD,
INSIGNIA CORPORATE HOUSE, AND SGS CEPHAC EUROPE
EAST HANOVER, NEW JERSEY


Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended ("Act"), 19 U.S.C. § 2273, the Department of Labor
herein presents the results of an investigation regarding
certification of eligibility to apply for worker adjustment
assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the
workers in such workers' firm have become totally or
partially separated, or are threatened to become
totally or partially separated;
(2)(B)(i)(I) there has been a shift by the workers'
firm to a foreign country in the production of
articles or supply of services like or directly
competitive with those produced/supplied by the
workers' firm; OR
(II) there has been an acquisition from a
foreign country by the workers' firm of
articles/services that are like or directly
competitive with those produced/supplied by
the workers' firm; AND
(ii) the shift/acquisition must have contributed
importantly to the workers' separation or
threat of separation.

The investigation was initiated in response to a petition
filed on February 8, 2017 on behalf of workers of Novartis
Pharmaceuticals Corporation, Novartis Institutes for
Biomedical Research (NIBR) Group, Early Bioanalytics &
Technology (EBT) Department, East Hanover, New Jersey
(Novartis-EBT). The Novartis-EBT is engaged in activities
related to the supply of biomedical research and analytics.
The subject worker group (Novartis-EBT) includes on-site
leased workers from Inventiv, WuXi AppTec, WuXi AppTec
Xenobiotic Laboratories, Covance US, Covance UK, Charles River
Canada, Veeda Clinical Research PVT. Ltd., Insignia Corporate
House, and SGS Cephac Europe.
During the course of the investigation, information was
collected from the workers' firm.
Section 222(a)(1) has been met because a significant
number or proportion of the workers in Novartis-EBT have become
totally or partially separated, or are threatened to become
totally or partially separated.
Section 222(a)(2)(B) has been met because the workers'
firm has acquired from a foreign country the supply of services
like or directly competitive with the biomedical research and
analytics services supplied by the subject workers which
contributed importantly to worker group separations at
Novartis-EBT.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Novartis-EBT, who are
engaged in activities related to the supply of biomedical
research and analytic services, meet the worker group
certification criteria under Section 222(a) of the Act, 19
U.S.C. § 2272(a). In accordance with Section 223 of the Act, 19
U.S.C. § 2273, I make the following certification:












"All workers of Novartis Pharmaceuticals Corporation,
Novartis Institutes for Biomedical Research (NIBR) Group,
Early Bioanalytics & Technology (EBT) Department,
including on-site leased workers from Inventiv, WuXi
AppTec, WuXi AppTec Xenobiotic Laboratories, Covance US,
Covance UK, Charles River Canada, Veeda Clinical Research
PVT. Ltd., Insignia Corporate House, and SGS Cephac
Europe, East Hanover, New Jersey, who became totally or
partially separated from employment on or after February 7,
2016 through two years from the date of certification, and
all workers in the group threatened with total or partial
separation from employment on the date of certification
through two years from the date of certification, are
eligible to apply for adjustment assistance under Chapter 2
of Title II of the Trade Act of 1974, as amended."
Signed in Washington, D.C. this 13th day of April 2017.
/s/Del Min Amy Chen
______________________________
DEL MIN AMY CHEN
Certifying Officer, Office of
Trade Adjustment Assistance